fanni
ws
margaret
alvin
h
rita
jojo
david
sc
dept
medicin
therapeut
chines
univers
hong
kong
hong
kong
dept
microbiolog
chines
univers
hong
kong
hong
kong
introduct
acut
exacerb
chronic
obstruct
pulmonari
diseas
aecopd
common
condit
lead
unschedul
health
care
util
impair
health
statu
among
patient
method
studi
assess
infect
etiolog
relat
aecopd
molecular
techniqu
includ
virus
bocaviru
human
metapneumoviru
novel
bacteria
like
streptococc
pseudopneumonia
also
studi
pair
sputum
sampl
panel
virus
subject
posit
nasophargn
aspir
npa
relationship
identif
short
term
clinic
outcom
patient
hospit
length
stay
need
ventil
mortal
month
assess
result
episod
aecopd
control
copd
subject
stabl
state
studi
overal
subject
posit
npa
commonest
virus
identifi
npa
aecopd
patient
rhinoviru
coronaviru
respiratori
syncyti
viru
control
subject
commonest
organ
detect
npa
specimen
atyp
organ
like
mycoplasma
pneumonia
chlamydia
pneumonia
aecopd
patient
control
subject
posit
sputum
bacteri
test
streptococcu
pseudopneumonia
identifi
subject
aecopd
among
subject
posit
npa
result
show
posit
result
pair
expector
sputum
comparison
subject
organ
identifi
npa
sputum
versu
npa
found
similar
demograph
characterist
short
term
clinic
outcom
conclus
role
high
preval
streptococc
pseudopneumonia
sputum
aecopd
patient
atyp
organ
like
mycoplasma
chlamydia
npa
stabl
copd
subject
need
investig
jusuf
wibisono
daniel
maranatha
wiwin
effendi
depart
pulmonolog
respiratori
medicin
faculti
medicin
universita
airlangga
surabaya
indonesia
background
hypoxemia
consequ
alveolar
hypoxia
increas
along
sever
copd
tissu
hypoxia
trigger
degrad
purin
serum
uric
acid
ua
final
product
purin
degrad
shown
increas
hypox
state
therefor
serum
ua
may
reflect
sever
hypoxia
assess
whether
presenc
higher
valu
serum
ua
associ
degre
sever
copd
method
research
conduct
outpati
pulmonari
clinic
soetomo
hospit
surabaya
east
java
indonesia
includ
consecut
patient
copd
patient
clinic
stabl
condit
without
signific
comorbid
condit
degre
sever
compar
oxygen
satur
valu
serum
ua
result
weak
correl
found
hypoxemia
degre
sever
copd
r
p
patient
level
satur
less
correl
serum
ua
valu
degre
sever
copd
present
signific
r
p
conclus
sever
copd
character
decreas
lung
function
result
increas
level
serum
uric
acid
patient
copd
muhammad
amin
ridmawan
w
jatmiko
depart
pulmonolog
respiratori
medicin
faculti
medicin
universita
airlangga
surabaya
indonesia
background
system
inflamm
may
contribut
cachexia
copd
patient
one
import
biomark
system
inflamm
aim
studi
analyz
correl
system
inflamm
nutrit
statu
chronic
obstruct
pulmonari
diseas
patient
method
studi
conduct
may
june
respond
stabl
copd
gold
patient
age
year
case
defin
copd
patient
poor
nutrit
statu
control
defin
copd
patient
good
nutrit
statu
nutrit
statu
measur
use
bodi
mass
index
bmi
percentag
ideal
bodi
weight
lean
bodi
mass
mass
serum
measur
use
enzym
immunoassay
correl
nutrit
statu
level
serum
analyz
univariat
multivariat
analysi
result
mean
serum
level
case
group
higher
control
group
pgml
vs
pgml
p
level
serum
correl
bmi
r
p
percentag
ideal
bodi
weight
r
p
lean
bodi
mass
r
p
mass
r
p
odd
ratio
ci
p
conclus
serum
correl
decreas
nutrit
statu
copd
patient
keyword
tumor
necrot
factor
system
inflamm
nutrit
statu
copd
masakazu
kourtney
j
dept
respiratori
medicin
tohoku
univers
graduat
school
medicin
miyagi
japan
glaxosmithklin
worldwid
epidemiolog
wavr
belgium
univers
ulsan
colleg
medicin
clinic
research
center
chronic
obstruct
airway
diseas
seoul
korea
background
aim
studi
survey
focus
directli
physician
perspect
treat
copd
physician
survey
aim
describ
physician
belief
behavior
relat
copd
diagnosi
treatment
includ
knowledg
revis
gold
strategi
countri
includ
japan
korea
method
sampl
physician
identifi
profession
associ
databas
includ
total
n
korea
gener
practition
gp
chest
physician
cp
n
interview
japan
gp
cp
standard
translat
questionnair
conduct
telephon
onlin
januari
may
result
awar
gold
strategi
overal
korea
overal
japan
knowledg
higher
among
cp
compar
gp
korea
vs
japan
vs
spirometri
korea
japan
chest
korea
japan
commonli
use
establish
copd
diagnosi
use
outcom
korea
japan
lower
countri
percent
korean
physician
japanes
physician
report
discuss
smoke
cessat
patient
everi
visit
perceiv
patient
adher
prescrib
treatment
regimen
low
korean
physician
japanes
physician
indic
least
patient
alway
compli
treatment
regimen
korean
japanes
physician
indic
medic
cost
common
barrier
access
adher
optim
regimen
conclus
awar
applic
gold
strategi
high
among
respiratori
specialist
physician
korea
japan
opportun
improv
gener
practition
deliv
care
copd
patient
identifi
sponsor
gsk
masakazu
yoshinosuk
depart
respiratori
medicin
tohoku
univers
graduat
school
medicin
miyagi
japan
depart
respiratori
medicin
juntendo
univers
tokyo
japan
object
aim
understand
symptom
actual
daili
behavior
degre
satisfact
patient
receiv
treatment
chronic
obstruct
pulmonari
diseas
copd
method
questionnair
survey
target
patient
medic
institut
special
pulmonari
medicin
carri
april
june
includ
patient
age
year
patient
visit
medic
institut
diagnos
copd
via
pulmonari
function
test
patient
provid
consent
particip
survey
treat
doctor
provid
data
pulmonari
function
number
exacerb
treatment
regimen
patient
result
patient
treat
use
inhal
drug
patient
indic
rel
high
degre
satisfact
treatment
cough
sputum
exert
dyspnea
depend
diseas
sever
frequent
observ
patient
report
cough
troublesom
accompani
sputum
h
awaken
exert
dyspnea
also
report
sever
awaken
continu
h
afternoon
patient
report
greater
number
exacerb
doctor
indic
doctor
probabl
complet
understand
suffer
patient
mari
grace
l
teresita
de
rommel
philippin
heart
center
east
avenu
quezon
citi
philippin
philippin
heart
center
east
avenu
quezon
citi
philippin
background
copd
assess
test
cat
develop
assist
patient
clinician
assess
quantifi
symptom
impact
copd
enabl
better
commun
patient
physician
consequ
diseas
alreadi
valid
countri
well
philippin
also
strong
correl
sgrq
method
studi
stabl
copd
patient
includ
studi
cat
sgrq
questionnair
administ
random
basi
data
describ
mean
sd
frequenc
percent
distribut
kappa
test
use
determin
signific
agreement
point
score
system
sever
copd
diagnos
spirometri
result
result
obtain
show
signific
impair
health
statu
relat
copd
sever
copd
sever
increas
cat
sgrq
score
also
increas
significantli
cat
p
sgrq
p
howev
signific
agreement
cut
score
cat
copd
sever
kappa
test
p
conclus
cat
show
signific
associ
health
relat
impact
copd
sever
good
correl
sgrq
score
system
jian
lin
youzu
xu
xiaomai
wu
meifang
chen
ling
lin
liuyang
gong
jiaxi
feng
depart
respiratori
medicin
taizhou
hospit
wenzhou
medic
colleg
linhai
zhejiang
china
background
aim
studi
readmiss
rate
deem
import
indic
qualiti
medic
care
china
object
studi
identifi
readmiss
rate
acut
exacerb
chronic
obstruct
pulmonari
diseas
copd
evalu
associ
risk
factor
method
retrospect
review
patient
acut
exacerb
copd
aecopd
hospit
januari
novemb
earli
readmiss
group
readmiss
group
determin
whether
patient
readmit
within
day
discharg
logist
regress
analysi
perform
identifi
risk
factor
earli
readmiss
follow
aecopd
result
patient
admiss
period
admiss
defin
earli
readmiss
multivari
analysi
show
chronic
pulmonari
heart
diseas
odd
ratio
confid
interv
ci
p
hypoproteinemia
ci
p
level
ci
p
risk
factor
earli
readmiss
aecopd
conclus
readmiss
rate
aecopd
high
aecopd
patient
chronic
pulmonari
heart
diseas
hypoproteinemia
high
level
risk
readmiss
day
hospit
discharg
medic
care
patient
warrant
much
greater
attent
shigeo
shintaro
hiroshi
tetsuya
tsutomu
kazuhiro
akihito
depart
hematolog
respiratori
medicin
kochi
univers
kochi
japan
depart
surgeri
kochi
univers
kochi
japan
background
chronic
obstruct
pulmonari
diseas
copd
recogn
system
inflammatori
diseas
although
viscer
adipos
tissu
inflamm
known
associ
variou
lifestyl
diseas
diabet
mellitu
atherosclerosi
contribut
system
inflamm
copd
remain
unclear
aim
studi
evalu
associ
lung
function
viscer
adipos
tissu
inflamm
method
studi
includ
patient
underw
surgic
resect
due
earli
stage
abdomin
cancer
gastric
colon
cancer
viscer
adipos
tissu
obtain
oper
inform
consent
quantifi
inflammatori
cell
adipos
tissu
evalu
associ
clinic
paramet
includ
lung
function
studi
approv
institut
ethic
committe
result
number
viscer
adipos
tissu
macrophag
atm
show
signific
correl
differ
patient
n
without
airflow
limit
n
howev
signific
neg
correl
atm
predict
vc
r
p
addit
signific
posit
correl
atm
bodi
mass
index
bmi
level
crp
significantli
higher
patient
low
predict
vc
multivari
analys
demonstr
predict
vc
bmi
independ
associ
number
viscer
atm
conclus
adipos
tissu
inflamm
may
contribut
system
inflamm
advanc
copd
low
lung
volum
independ
bmi
